Skip to Content

International Stem Cell Corp ISCO Stock Quote

| Rating as of


Last close prices updated as of Feb 07, 2023, 1:28 PM EST | USD
  • Last Close 0.2
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.20  –  0.20
  • Year Range 0.11  –  0.54
  • Market Cap 1.6009 Mil
  • Volume / Avg 104.0 /  6,152.0
  • Price / Sales 0.21
  • Price / Book 1.56
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis ISCO

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ISCO

Company Profile ISCO

Business Description

International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, therapeutic market, biomedical market, and anti-aging market. The Biomedical products business segment accounts for the majority of revenue.

9745 Businesspark Avenue
San Diego, CA, 92131
Industry Biotechnology
Employees 29

FAQs for International Stem Cell Corp Stock

No. ISCO does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ISCO’s market cap is 1.60 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ISCO’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ISCO’s historical performance against its industry peers and the overall market.